IPDD WG 1 Member, Structure-based drug design, LINXS Fellow

Tobias Krojer is project manager of the FragMAX facility for crystal-based fragment screening at MAX IV Laboratory. He is interested in developing methods for accelerated structure-based drug development at synchrotron sources.